Morgan Stanley’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-107,649
| Closed | -$125K | – | 8207 |
|
|
2022
Q2 | $125K | Sell |
107,649
-33,391
| -24% | -$34.9K | ﹤0.01% | 6157 |
|
|
2022
Q1 | $152K | Sell |
141,040
-236,750
| -63% | -$179K | ﹤0.01% | 6070 |
|
|
2021
Q4 | $271K | Sell |
377,790
-185,250
| -33% | -$150K | ﹤0.01% | 5898 |
|
|
2021
Q3 | $507K | Buy |
563,040
+117,027
| +26% | +$141K | ﹤0.01% | 5490 |
|
|
2021
Q2 | $740K | Buy |
446,013
+183,518
| +70% | +$307K | ﹤0.01% | 5263 |
|
|
2021
Q1 | $549K | Buy |
262,495
+209,117
| +392% | +$434K | ﹤0.01% | 5099 |
|
|
2020
Q4 | $67K | Buy |
53,378
+39,286
| +279% | +$46.9K | ﹤0.01% | 6063 |
|
|
2020
Q3 | $17K | Sell |
14,092
-15,514
| -52% | -$18.9K | ﹤0.01% | 6124 |
|
|
2020
Q2 | $34K | Buy |
29,606
+16,793
| +131% | +$15.5K | ﹤0.01% | 5827 |
|
|
2020
Q1 | $10K | Sell |
12,813
-68,231
| -84% | -$72.3K | ﹤0.01% | 6025 |
|
|
2019
Q4 | $81K | Buy |
81,044
+55,259
| +214% | +$67K | ﹤0.01% | 5717 |
|
|
2019
Q3 | $37K | Buy |
25,785
+17,701
| +219% | +$25K | ﹤0.01% | 5835 |
|
|
2019
Q2 | $12K | Sell |
8,084
-10,611
| -57% | -$16.4K | ﹤0.01% | 6090 |
|
|
2019
Q1 | $28K | Sell |
18,695
-98,378
| -84% | -$150K | ﹤0.01% | 5910 |
|
|
2018
Q4 | $172K | Sell |
117,073
-11,844
| -9% | -$18.1K | ﹤0.01% | 5342 |
|
|
2018
Q3 | $236K | Buy |
128,917
+12,010
| +10% | +$23.3K | ﹤0.01% | 5375 |
|
|
2018
Q2 | $215K | Buy |
116,907
+116,427
| +24,256% | +$217K | ﹤0.01% | 5504 |
|
|
2018
Q1 | $1K | Hold |
480
| – | – | ﹤0.01% | 6567 |
|
|
2017
Q4 | $1K | Hold |
480
| – | – | ﹤0.01% | 6525 |
|
|
2017
Q3 | $1K | Sell |
480
-40
| -8% | -$46 | ﹤0.01% | 6486 |
|
|
2017
Q2 | $1K | Buy |
520
+40
| +8% | +$57 | ﹤0.01% | 6541 |
|
|
2017
Q1 | $1K | Hold |
480
| – | – | ﹤0.01% | 6524 |
|
|
2016
Q4 | $1K | Hold |
480
| – | – | ﹤0.01% | 6475 |
|
|
2016
Q3 | $1K | Hold |
480
| – | – | ﹤0.01% | 6455 |
|
|
2016
Q2 | $0 | Sell |
480
-1,456
| -75% | -$1.13K | ﹤0.01% | 6723 |
|
|
2016
Q1 | $1K | Sell |
1,936
-7,215
| -79% | -$7.26K | ﹤0.01% | 6499 |
|
|
2015
Q4 | $10K | Sell |
9,151
-32,925
| -78% | -$70.5K | ﹤0.01% | 6247 |
|
|
2015
Q3 | $88K | Sell |
42,076
-508
| -1% | -$990 | ﹤0.01% | 5476 |
|
|
2015
Q2 | $84K | Buy |
42,584
+37,293
| +705% | +$106K | ﹤0.01% | 5675 |
|
|
2015
Q1 | $20K | Sell |
5,291
-17,221
| -76% | -$63.8K | ﹤0.01% | 6046 |
|
|
2014
Q4 | $82K | Sell |
22,512
-4,903
| -18% | -$13K | ﹤0.01% | 5634 |
|
|
2014
Q3 | $73K | Sell |
27,415
-9,094
| -25% | -$60.8K | ﹤0.01% | 5596 |
|
|
2014
Q2 | $425K | Buy |
36,509
+525
| +1% | +$5.95K | ﹤0.01% | 4705 |
|
|
2014
Q1 | $503K | Buy |
35,984
+35,837
| +24,379% | +$563K | ﹤0.01% | 4544 |
|
|
2013
Q4 | $3K | Sell |
147
-23,916
| -99% | -$388K | ﹤0.01% | 6226 |
|
|
2013
Q3 | $405K | Buy |
+24,063
| New | +$338K | ﹤0.01% | 4470 |
|
Morgan Stanley's MBII Position: Q3 2022 in Review
Morgan Stanley sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 107,649 shares — an estimated $125K sold.
Morgan Stanley first reported a position in MBII in Q3 2013 and held it in 36 quarters. The position peaked at $740K in Q2 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- Morgan Stanley reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- Morgan Stanley sold 107,649 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $125K.
- Morgan Stanley first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 36 quarters.
- Morgan Stanley's Marrone Bio Innovations, Inc. position peaked at $740K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.